{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:18:29Z","timestamp":1767676709051},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.contraception.2008.06.008","type":"journal-article","created":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T14:03:39Z","timestamp":1217858619000},"page":"392-398","source":"Crossref","is-referenced-by-count":11,"title":["The emotional impact of genetic testing and aspects of counseling prior to prescription of oral contraceptives"],"prefix":"10.1016","volume":"78","author":[{"given":"Verena","family":"Gartner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Eichinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2008.06.008_bib1","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(61)91061-3","article-title":"Pulmonary embolism","volume":"278","author":"Jordan","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.06.008_bib2","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/humrep\/13.11.2981","article-title":"Venous thromboembolism and the pill. The WHO technical report on cardiovascular disease and steroid hormone contraception: state-of-the-art. World Health Organization","volume":"13","author":"Helmerhorst","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2008.06.008_bib3","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.06.008_bib4","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.06.008_bib5","first-page":"967","article-title":"Oral contraception: trends over time","volume":"47","author":"Yuzpe","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2008.06.008_bib6","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlback","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.contraception.2008.06.008_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.contraception.2008.06.008_bib8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(05)80081-9","article-title":"Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study","volume":"342","author":"Koster","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.06.008_bib9","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504","article-title":"High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)","volume":"85","author":"Rosendaal","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2008.06.008_bib10","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.06.008_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1034\/j.1600-0412.2003.00118.x","article-title":"Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women","volume":"82","author":"Lindqvist","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2008.06.008_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0950-3552(97)80028-4","article-title":"The pill and thrombosis: epidemiological considerations","volume":"11","author":"Carter","year":"1997","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2008.06.008_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1515\/CCLM.2006.103","article-title":"Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening","volume":"44","author":"Andreassi","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.contraception.2008.06.008_bib14","series-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organisation (WHO)","year":"2004"},{"key":"10.1016\/j.contraception.2008.06.008_bib15","series-title":"Faculty of Family Planning and Reproductive Health Care of the Royal College of Obstetricians and Gynaecologists","year":"2007"},{"key":"10.1016\/j.contraception.2008.06.008_bib16","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1046\/j.1538-7836.2003.00448.x","article-title":"Knowledge and educational needs of individuals with the factor V Leiden mutation","volume":"1","author":"Hellmann","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2008.06.008_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1160\/TH06-01-0015","article-title":"Psychological impact of testing for thrombophilic alterations","volume":"96","author":"Legnani","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2008.06.008_bib18","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/j.1538-7836.2005.01619.x","article-title":"Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency","volume":"3","author":"Van Korlaar","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2008.06.008_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","article-title":"Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study","volume":"57","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.06.008_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.160.1.49","article-title":"Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects","volume":"160","author":"Bloemenkamp","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2008.06.008_bib21","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.06.008_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM200002103420602","article-title":"Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium","volume":"342","author":"Gerhardt","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2008.06.008_bib23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078240800334X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078240800334X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T12:13:33Z","timestamp":1588853613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078240800334X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S001078240800334X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2008.06.008","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}